A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Zespri on track for 'moderate increase' in volume next year
Primary Sector

Zespri on track for 'moderate increase' in volume next year

Zespri's producer vote to expand global supply passed this week.

Riley Kennedy 12 Dec 2024
Yashili NZ revenue dropped 42%
Primary Sector

Yashili NZ revenue dropped 42%

The Chinese-owned dairy processor’s accounts were due in May.

Riley Kennedy 12 Dec 2024
Zespri growers vote in favour of expanding global supply
Primary Sector

Zespri growers vote in favour of expanding global supply

Zespri’s growers have voted to support the expansion of the kiwifruit marketer’s global supply.A total of 90.6% of voting growers and 93.3% by fruit weight voted in favour of the resolution, which will allocate up to 420 hectares of SunGold fruit per year over six years in Italy,...

Riley Kennedy 11 Dec 2024